Clinical Trial Update: Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 umbrella trial from Tianjin Medical University Cancer Institute and Hospital investigating first-line treatment options for extensive-stage s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Extensive Stage Lung Small Cell Cancer | Phase 2 | Status: NOT_YET_RECRUITING